XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Total
Beginning balance, value at Dec. 31, 2023 $ 490,899 $ 47,018,707 $ (23,312,273) $ (3,843,562) $ 20,353,771
Ending balance (in shares) at Dec. 31, 2023 49,089,864        
Issuance of stock-based compensation $ 537 123,267 123,804
Issuance of stock-based compensation (in shares) 53,725        
Compensation expense related to stock options 393,113 393,113
Compensation related to restricted stock 130,676 130,676
Issuance of warrants 52,125 52,125
Net loss (1,935,958) (1,935,958)
Ending balance, value at Mar. 31, 2024 $ 491,436 47,717,888 (25,248,231) (3,843,562) 19,117,531
Ending balance (in shares) at Mar. 31, 2024 49,143,589        
Beginning balance, value at Dec. 31, 2023 $ 490,899 47,018,707 (23,312,273) (3,843,562) 20,353,771
Ending balance (in shares) at Dec. 31, 2023 49,089,864        
Net loss         (4,505,490)
Ending balance, value at Sep. 30, 2024 $ 492,758 48,940,978 (27,817,763) (3,882,493) 17,733,480
Ending balance (in shares) at Sep. 30, 2024 49,275,830        
Beginning balance, value at Mar. 31, 2024 $ 491,436 47,717,888 (25,248,231) (3,843,562) 19,117,531
Ending balance (in shares) at Mar. 31, 2024 49,143,589        
Issuance of stock-based compensation $ 411 136,020 (38,932) 97,500
Issuance of stock-based compensation (in shares) 41,138        
Compensation expense related to stock options 401,218 401,218
Compensation related to restricted stock $ 551 63,434 63,984
Compensation expense related to restricted stock (in shares) 55,061        
Issuance of warrants 13,032 13,032
Net loss (988,715) (988,715)
Ending balance, value at Jun. 30, 2024 $ 492,398 48,331,591 (26,236,946) (3,882,493) 18,704,550
Ending balance (in shares) at Jun. 30, 2024 49,239,788        
Issuance of stock-based compensation $ 360 97,140 97,500
Issuance of stock-based compensation (in shares) 36,042        
Compensation expense related to stock options 305,376 305,376
Compensation related to restricted stock 193,839 193,839
Issuance of warrants 13,032 13,032
Net loss (1,580,817) (1,580,817)
Ending balance, value at Sep. 30, 2024 $ 492,758 48,940,978 (27,817,763) (3,882,493) 17,733,480
Ending balance (in shares) at Sep. 30, 2024 49,275,830        
Beginning balance, value at Dec. 31, 2024 $ 493,776 49,581,303 (29,378,906) (3,882,494) 16,813,679
Ending balance (in shares) at Dec. 31, 2024 49,377,617        
Issuance of stock-based compensation $ 1,839 95,661 97,500
Issuance of stock-based compensation (in shares) 183,881        
Compensation expense related to stock options 359,197 359,197
Compensation related to restricted stock 227,860 227,860
Issuance of warrants 13,032 13,032
Net loss (1,166,237) (1,166,237)
Ending balance, value at Mar. 31, 2025 $ 495,615 50,277,053 (30,545,143) (3,882,494) 16,345,031
Ending balance (in shares) at Mar. 31, 2025 49,561,498        
Beginning balance, value at Dec. 31, 2024 $ 493,776 49,581,303 (29,378,906) (3,882,494) 16,813,679
Ending balance (in shares) at Dec. 31, 2024 49,377,617        
Net loss         (2,151,070)
Ending balance, value at Sep. 30, 2025 $ 497,137 51,380,158 (31,529,976) (3,882,494) 16,464,825
Ending balance (in shares) at Sep. 30, 2025 49,713,694        
Beginning balance, value at Mar. 31, 2025 $ 495,615 50,277,053 (30,545,143) (3,882,494) 16,345,031
Ending balance (in shares) at Mar. 31, 2025 49,561,498        
Issuance of stock-based compensation $ 940 96,560 97,500
Issuance of stock-based compensation (in shares) 93,961        
Compensation expense related to stock options 147,944 147,944
Compensation related to restricted stock 142,766 142,766
Net loss (206,867) (206,867)
Ending balance, value at Jun. 30, 2025 $ 496,555 50,664,323 (30,752,010) (3,882,494) 16,526,374
Ending balance (in shares) at Jun. 30, 2025 49,655,459        
Issuance of stock-based compensation $ 254 97,246 97,500
Issuance of stock-based compensation (in shares) 25,454        
Compensation expense related to stock options 254,697 254,697
Compensation related to restricted stock 275,195 275,195
Net loss (777,966) (777,966)
Proceeds from exercise of employee stock options $ 328 88,697 89,025
Proceeds from exercise of employee stock options (in shares) 32,781        
Ending balance, value at Sep. 30, 2025 $ 497,137 $ 51,380,158 $ (31,529,976) $ (3,882,494) $ 16,464,825
Ending balance (in shares) at Sep. 30, 2025 49,713,694